Literature DB >> 9513208

[Autoantibody to glutamate decarboxylase in a patient with spinocerebellar degeneration and Sjögren syndrome].

J Ikeda1, T Harada, H Kamei, S Nakamura.   

Abstract

We report a 52-year-old woman with Sjögren syndrome from the age of 46, developed cerebellar ataxia, autonomic dysfunction and dysarthria at 50. She had no family history, and all known causes of cerebellar disease were excluded. Serum of the patient contained autoantibodies directed against glutamic acid decarboxylase (GAD) which was an enzyme involved in the biosynthesis of GABA. She also had autoantibodies that were specific with Sjögren syndrome (SS-A, anti-nuclear antibody). Anti-GAD antibody changed into negative after high dose intravenous and oral corticosteroid therapy, but symptoms did not improve. Western blot method revealed abnormal bands to human neuroblastoma cell line (10, 43, 49 kDa), considered relatively specific to nervous tissue. In this case cerebellar ataxia and atrophy were caused by autoimmune pathogenesis including cerebellar GABAergic system and central nerve cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513208

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  3 in total

1.  Low-titer anti-GAD-antibody-positive cerebellar ataxia.

Authors:  Kazunori Nanri; Hisayoshi Niwa; Hiroshi Mitoma; Asako Takei; Junko Ikeda; Toshihide Harada; Mitsunori Okita; Masafumi Takeguchi; Takeshi Taguchi; Hidehiro Mizusawa
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

2.  Asymmetric cerebellar ataxia and limbic encephalitis as a presenting feature of primary Sjögren's syndrome.

Authors:  Kiren Collison; Jeremy Rees
Journal:  J Neurol       Date:  2007-09-12       Impact factor: 6.682

3.  Deciphering potential pharmacological mechanism of Sha-Shen-Mai-Dong decoction on primary Sjogren's syndrome.

Authors:  Yuepeng Jiang; Xiaoxuan Zhao; Jie Yu; Qiao Wang; Chengping Wen; Lin Huang
Journal:  BMC Complement Med Ther       Date:  2021-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.